CBR Pharma Insights Market Research Reports

TITLE Actions
Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players
Published in Oct 2018 | US $ 2995 Onwards | By CBR Pharma Insights

Summary GBI Research’s latest report, Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players, explores the application of exosome technologies within the pharmaceu...

The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players
Published in May 2018 | US $ 2995 Onwards | By CBR Pharma Insights

GBI Research’s latest report, The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players, provides an in-depth assessment of the current trends in the global mid-size pharma market, a...

Artificial Intelligence Technologies: Market Prospects - Featuring Expert Panel Views from Industry Survey 2018
Published in Mar 2018 | US $ 2995 Onwards | By CBR Pharma Insights

GBI Research’s latest report: “Artificial Intelligence Technologies: Market Prospects - Featuring Expert Panel Views From Industry Survey 2018” considers the current and future impact of artificial intelligence (AI) technologies ...

Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products such as Glybera and Strimvelis
Published in Feb 2018 | US $ 2995 Onwards | By CBR Pharma Insights

Summary “Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products such as Glybera and Strimvelis” dis...

Cosmeceuticals: Global Trends in Market Entry Strategies, Regulatory Framework, Next-Generation Products and Technologies
Published in Feb 2018 | US $ 2995 Onwards | By CBR Pharma Insights

Summary Latest report, Cosmeceuticals: Global Trends in Market Entry Strategies, Regulatory Framework, Next-Generation Products and Technologies, provides an in-depth assessment of the current trends in the global cosmeceu...

Nutraceuticals: New Applications for Probiotics, Genetic Modification and Diet as Products Make Gains in Rx Territory
Published in Dec 2017 | US $ 2995 Onwards | By CBR Pharma Insights

Summary The nutraceuticals market is growing and diversifying rapidly. These products are linked by the fact that they are dietary products that have some degree of either purported or clinically evidenced medical benefit....

Monoclonal Antibodies - Global Trends in the Competitive, Technological and R&D Landscape
Published in Nov 2017 | US $ 2995 Onwards | By CBR Pharma Insights

Antibodies, otherwise known as immunoglobulins (Ig), are large, Y-shaped glycoproteins produced by immune cells in response to pathogens such as bacteria and viruses. They consist of two large heavy polypeptide chains and two smaller light polypep...

A Global Hyperhidrosis Market Landscape Assessment: Trends, Forecasts and Opportunities in a Growing Market
Published in Oct 2017 | US $ 2995 Onwards | By CBR Pharma Insights

Hyperhidrosis is a chronic disorder of excessive sweating beyond thermoregulatory needs and environmental conditions. It commonly arises in childhood and adolescence, and can affect patients for many years. Most cases of hyperhidrosis involve area...

Current and Future Trends in Rx-to-OTC Switching with Insight from Key Industry Opinion Leaders
Published in Oct 2017 | US $ 2995 Onwards | By CBR Pharma Insights

Summary Rx-to-OTC switching is the process of transferring Rx pharmaceuticals to non-prescription OTC status for the same dosage form, population, and route of administration. OTC drugs are defined as those that are safe a...

Pharmaceutical Deal Trends 2017 Factbook: Partnerships and Acquisitions Shift Focus Towards Early Stage Development, Emerging Markets, and Biologics
Published in Jul 2017 | US $ 2995 Onwards | By CBR Pharma Insights

Summary Pharmaceutical market is continuing to see global growth, whereas pharmaceutical and biotechnology companies are facing challenges due to disruptive events in the healthcare market such as increasing costs of produ...

Mobile Health (mHealth) Technologies: Global Market Prospects - Featuring Expert Panel Views from Industry Survey 2017
Published in Jun 2017 | US $ 2995 Onwards | By CBR Pharma Insights

Summary mHealth is often regarded as a branch of eHealth, which has been defined by the European Commission as “The use of modern information and communication technologies to meet needs of citizens, patients, health...

Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline
Published in May 2017 | US $ 2995 Onwards | By CBR Pharma Insights

Summary Innovation is a crucial element of the pharmaceutical industry. The market is highly research-intensive, being deeply reliant on a high level of R&D investment and a strong product pipeline to maintain growth a...

Pharmaceutical Lifecycle Management Strategies in 2017
Published in Apr 2017 | US $ 2995 Onwards | By CBR Pharma Insights

Pharmaceutical lifecycle management (LCM) is the process of managing the entire lifecycle of a product including its research, design and manufacture, service and disposal. LCM is a well-established tool to maximize sales throughout the product li...

Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through Risk Management and Quality by Design
Published in Mar 2017 | US $ 2995 Onwards | By CBR Pharma Insights

Summary Government support for biosimilars is increasing in key geographical markets, given the cost saving opportunities that these products represent for national healthcare budgets. A biosimilar is a bio-therapeutic tha...

Evolving Pharmaceutical Marketing Strategies: Digital as a Key Component of Multichannel Marketing
Published in Feb 2017 | US $ 2995 Onwards | By CBR Pharma Insights

Multichannel marketing (MCM) refers to the integration of various marketing channels into an overall synergetic strategy. Utilization of information from all the channels in a feedback loop is termed closed-loop marketing (CLM). While they require...

Big Data: Embracing Data to Transform Healthcare and Pharma Commercial Strategy - Featuring Expert Panel Views from Industry Survey 2016
Published in Dec 2016 | US $ 2995 Onwards | By CBR Pharma Insights

Data generation is growing at an exponential rate, so much so that 90% of the data in the world today was created in the last two years (IBM, 2016a). Big Data refers to any data set that is too large to store, process or analyze using traditional ...

Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during the Forecast Period
Published in Nov 2016 | US $ 2995 Onwards | By CBR Pharma Insights

Drug delivery technologies are engineered technologies that deliver drugs to achieve a therapeutic effect. Advances in these technologies usually aim to increase the efficacy of the drug, improve drug absorption and decrease side effects. The glob...

Strategic Trends in Private Equity and Venture Capital Funding for Healthcare
Published in Nov 2016 | US $ 2995 Onwards | By CBR Pharma Insights

Private Equity is a term used to refer to money invested in private companies, and those companies become private through investment. However, in the financial industry the term is used to refer to firms that buy companies through leveraged buyout...

The Future of Generic Drugs and Strategies for Commercial Success
Published in Sep 2016 | US $ 2995 Onwards | By CBR Pharma Insights

Generic drugs are identical or bioequivalent to branded drugs in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use. Although generic drugs are chemically identical to their branded counte...

Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape
Published in Jul 2016 | US $ 2995 Onwards | By CBR Pharma Insights

GBI Research’s latest report, ""Stem Cell Therapies Global Trends in the Competitive, Technological and R&D Landscape"" provides an in-depth assessment of the current trends in the global stem cell therapy sector with...

We are on:

Need Help?